A research team led by Professor Bae Hee-joon of the Department of Neurology at Seoul National University Bundang Hospital ...

Compared with the use of other migraine medications, use of erenumab did not increase cardiovascular or cerebrovascular risks.

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

Does long-term colchicine use plus guideline-based care after ischemic stroke prevent recurrent vascular events?

In the SOUL trial, Rybelsus produced a 14% risk reduction of major adverse cardiovascular events in patients with type 2 ...

The County of Santa Clara, Calif., has assumed ownership and operations of Regional Medical Center in San Jose, Calif., ...

Bagsværd, Denmark Tuesday, April 1, 2025, 18:00 Hrs [IST] ...

Leading up to his benefit shows, Jesse Malin practiced rising from a seated position daily using a raised microphone stand in his living room ...

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral ...

The statement by Executive Director at Lancet Countdown, Marina Belen Romanello, cames as a report by the Indian government ...

The identity of the new 'Newtitzer' joining Channel A 'Please Take Care of My Performance: Teachers 2' has been revealed as ...

Researchers, including those at the University of North Carolina, US, found that the oral form of Semaglutide can ...